Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance [Phase 2]
A Phase 2 maintenance trial for relapsed multiple myeloma using cyclophosphamide and bortezomib has completed. Sponsored by University Medic…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Phase I Study of OPB-51602 in Patients With Hematologic Malignancies [Phase 1]
Phase I trial results are reported for OPB-51602 in patients with hematologic malignancies including multiple myeloma, non-Hodgkin lymphoma,…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain [Phase 1]
Phase 1 trial evaluating oral bicarbonate as an adjuvant for pain reduction in patients with tumor-related pain was terminated.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma [Phase 1]
Phase 1b multicenter trial evaluating carfilzomib in combination with lenalidomide and dexamethasone for relapsed multiple myeloma has compl…
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating chloroquine with VELCADE and cyclophosphamide in relapsed/refractory multiple myeloma; study terminated with posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma [Phase 3]
Phase 3 trial evaluating DOXIL (pegylated liposomal doxorubicin) in combination with Velcade versus Velcade monotherapy for relapsed multipl…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma [Phase 2]
Phase II trial of Anti-KIR in smoldering multiple myeloma was terminated; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma [Phase 1, Phase 2]
This document reports dose-finding results for lenalidomide used as maintenance therapy in patients with multiple myeloma in a Phase 1/2 tri…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) [Phase 1]
Phase 1 update on weekly dosing of SCH 727965 in patients with advanced cancer, including solid tumors, non-Hodgkin lymphoma, multiple myelo…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.
This observational study assesses the safety and effectiveness of bortezomib at first relapse after participation in HOVON-49/50 first-line …
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial of a viral therapy for relapsed or refractory multiple myeloma has completed enrollment. The trial also included pati…
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
A Phase II study evaluating the bone-related effects of bortezomib in relapsed or refractory multiple myeloma; the trial was terminated with…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
A SWOG trial (NCT00919139) evaluating a blood/bone marrow repository from patients with multiple myeloma, smoldering myeloma, Waldenström's …
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial of bendamustine hydrochloride combined with lenalidomide and dexamethasone for relapsed/refractory multiple myeloma has comp…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma [Phase 2]
Phase 2 trial evaluating green tea extract in patients with MGUS and/or smoldering multiple myeloma; the study was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma [Phase 2]
Phase 2 trial update evaluating panobinostat in patients with relapsed and bortezomib-refractory multiple myeloma; results posted after comp…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). [Phase 3]
Phase 3 open-label, single-arm trial evaluating safety and efficacy of Plerixafor with G-CSF for front-line mobilization in lymphoma and mul…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).
Long-term follow-up study of multiple myeloma patients who received plerixafor or placebo in the AMD3100-3102 trial. The study status is COM…
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma. [Phase 2]
A Phase 2 trial evaluated palbociclib in combination with Velcade (bortezomib) and dexamethasone in patients with multiple myeloma and has c…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial update reporting on FR901228 for relapsed or refractory multiple myeloma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating tivantinib for relapsed or relapsed and refractory multiple myeloma has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating palifermin for reducing oral mucositis in patients with multiple myeloma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating the combination of bortezomib and tipifarnib for relapsed or refractory multiple myeloma; the trial status is compl…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of melphalan and bortezomib given before autologous stem cell transplant in multiple myeloma; the…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluated a combination of bortezomib, lenalidomide, and dexamethasone in multiple myeloma patients undergoing stem cell tra…